8-K - NASDAQ DELISTING

Company

Eledon Pharmaceuticals, Inc.

Filed

February 7, 2020

Period of Report

February 6, 2020

Accession Number

0001564590-20-003758

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →